Scholar Rock – a biotechnology company focused on discovering and developing drugs that selectively target growth factors in the disease microenvironment – announced the publication of “Blocking extracellular activation of myostatin as a strategy for treating muscle wasting,” in Scientific Reports, the peer-reviewed, open-access journal published by Nature.
Array BioPharma sued AstraZeneca, accusing the pharmaceutical company of refusing to pay required royalties for a cancer drug after entering into an $8.5 billion collaboration with Merck & Co.
FDA Approves Avycaz for Treatment of Patients with Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia
The U.S. FDA approved Allergan’s supplemental New Drug Application to expand the approved use of Avycaz (ceftazidime and avibactam) to include the treatment of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia caused by certain susceptible Gram-negative microorganisms.
Anika announced a research collaboration with the Institute of Integrative Biology at the University of Liverpool to develop an injectable mesenchymal stem cell therapy for osteoarthritis.
The Vilcek Foundation announced the winners of the 2018 Vilcek Prizes in Biomedical Science. Awarded annually, the prizes call attention to the breadth of immigrant contributions to science in the United States. In parallel, the Vilcek Foundation also awards prizes for immigrant accomplishments in the arts.
Insys Therapeutics Inc.’s legal woes deepened as New York’s attorney general filed a lawsuit seeking at least $75 million from the company.
Shares of South Korea-based Celltrion were down more than 5 percent after the company announced it received a warning letter from the U.S. Food and Drug Administration after the regulatory agency inspected a company drug manufacturing facility.
One week after launching, Partner Therapeutics acquired the global rights to Leukine (sargramaostin) from Paris-based Sanofi.
First reported by FierceBiotech, Roche’s financial reports indicated the company was cutting a total of four drugs: One late-stage product and three drugs in Phase I development.
The goal of “Forever Welcome” is to help ensure that the United States is a safe place for immigrants to pursue their dreams.
Publicis Health, a division of Publicis Groupe, announced the elevation of Alexandra von Plato to the role of Chief Executive Officer for Publicis Health effective immediately.
Senior executives in manufacturing operations within large global corporations selected the Thermo Scientific InSight wireless cold storage monitoring solution as the winner of the 2017 Manufacturing Leaders’ Innovation Award.
W2O announced the appointment of Rita Glaze as Practice Leader of Value, Pricing and Market Access to strengthen its healthcare commercialization offering.
Researchers in Japan and Australia say they have made important progress in developing a blood test that could in future help doctors detect who might go on to get Alzheimer’s disease.